On the heels of Russia’s questionably early commencement of public production of the COVID-19 vaccine, leading SARS-CoV-2 vaccine manufacturers are quickly approaching the Thanksgiving vaccine moment.
Pfizer and BioNTech biopharmaceutics announced today a $1.95 billion dollar agreement with the U.S. government for 100 million doses of the partnership's BNT162 program vaccine.
This week, The Guardian reported on a growing concern the Trump administration may be pressuring government agencies including the FDA to approve a COVID-19 vaccine in time for the US election
Today, an unnamed source in the White House administration spoke with Yahoo News taking a different tone, "We cannot promise a 100 percent chance of success.” Since then...
The Trump Administration’s “Operation Warp Speed” which promises millions of vaccines by the early 2021, may be fanning the flames of an increasingly vaccine-hesitant public, experts warn.
According to a report in the New York Times today, the White House has selected five pharmaceutical companies as finalists for funding for “Operation Warp Speed.”
In a press release yesterday, US company Emergent BioSolutions announced they have been called upon by the US government under their existing contract to support Trump's controversially aggressive "Project Warpspeed."